 canadian cooper trial cyclophosphamid plasma exchang progress multipl sclerosi canadian cooper multipl sclerosi studi group non-specif immunosuppress benefici multipl sclerosi MS placebo-control single-mask trial univers centr patient laboratory-support definit MS progress phase deterior disabl statu scale edss previou year intraven cyclophosphamid oral prednison daili oral cyclophosphamid altern day prednison week exchang week medic plasma exchang patient month mean month monitor neurologist awar treatment alloc evalu neurologist primari analysi comparison rate treatment failur worsen neurologist assess edss consecut assess signific differ group primari analysi treatment failur cyclophosphamid plasma exchang placebo differ proport month assess mean chang edss final assess cyclophosphamid plasma exchang placebo slight trend plasma exchang group month follow-up final assess studi previou report immunosuppress treatment stabilis improv progress MS